US regulatory status: approved. Molecular target: Estrogen receptor.
- Target
- Estrogen receptor
- Mechanism
- Estrogen receptor alpha agonist
biotech · Hypertrophic Cardiomyopathy · Arrhythmogenic Right Ventricular Cardiomyopathy · TNYA
Tenaya Therapeutics
Tenaya Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
South San Francisco, USA HQ
2016 Founded
99 Employees
Public company Type
TNYA · NYSE Ticker
Company details
- Status
- Public
- HQ
- South San Francisco, USA
- Founded
- 2016
- Employees
- 99
- Programs
- 2
- Drugs
- 1
- Patents
- 13
Tenaya Therapeutics pipeline
Portfolio lens on 1 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Tenaya Therapeutics drug portfolio — 1 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.